Previously treated cases tested for RR-/MDR-TB (%) in Poland
Poland: Previously treated cases tested for RR-/MDR-TB was 80.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Poland, 2007–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Poland is 80.0%, measured in 2024.
The figure is down 3.6% on the previous year and up 21.2% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Poland peaked at 89.0% in 2018 and was at its lowest, 50.0%, in 2007.
That places Poland 114th out of 180 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Previously treated cases tested for RR-/MDR-TB in Poland, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 50.0% | — |
| 2008 | 60.0% | +20.0% |
| 2009 | 50.0% | -16.7% |
| 2010 | 52.0% | +4.0% |
| 2011 | 60.0% | +15.4% |
| 2012 | 62.0% | +3.3% |
| 2013 | 58.0% | -6.5% |
| 2014 | 66.0% | +13.8% |
| 2015 | 65.0% | -1.5% |
| 2016 | 62.0% | -4.6% |
| 2017 | 59.0% | -4.8% |
| 2018 | 89.0% | +50.8% |
| 2019 | 85.0% | -4.5% |
| 2020 | 86.0% | +1.2% |
| 2021 | 83.0% | -3.5% |
| 2022 | 83.0% | +0.0% |
| 2023 | 83.0% | +0.0% |
| 2024 | 80.0% | -3.6% |
Poland compared with similar countries
- Poland's 80.0% is below the median for high income countries, which is 83.0%, 96% of the median. (57 countries reporting)
- Poland's 80.0% is below the median for Europe & Central Asia, which is 86.0%, 93% of the median. (49 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Poland changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2018 | +50.8% | 59.0% | 89.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 53.3% | 50.0% | 60.0% | 3 |
| 2010s | 65.8% | 52.0% | 89.0% | 10 |
| 2020s | 83.0% | 80.0% | 86.0% | 5 |
Countries ranked near Poland
More health data for Poland
- Un projection of annual infant deaths, annual growth rate -1.23 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,693 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.59 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0201 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.49 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Poland?
- Previously treated cases tested for rr-/mdr-tb in Poland was 80.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Poland?
- The highest recorded value was 89.0% in 2018.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Poland?
- The lowest recorded value was 50.0% in 2007.
- How does Poland rank for previously treated cases tested for rr-/mdr-tb?
- Poland ranks 114th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Poland?
- Over the last ten years it is up 21.2%. The long-run trend across the full record is rising.
- Where does this Poland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).